1.
Zhou WX, Fan JH, Ni QW, et al. Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment. World J Oncol. Published online January 9, 2026. doi:10.14740/wjon2685